Insulet
Acton
About Insulet
Insulet is a medical device company improving the lives of people with diabetes and other conditions through its omnipod delivery system. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Total funding: $629.5M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2025)
- Ticker: nasdaq:PODD
- Website: insulet.com
- Phone: +1 978 600 7000
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/insulet-88947 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.